Latest news with #NEI
Malaysian Reserve
4 days ago
- Health
- Malaysian Reserve
MindHYVE.ai Partners with ICS Pakistan and NEI Pakistan to Revolutionize Nursing Education with AI-Powered ArthurAI
ISLAMABAD, Aug. 12, 2025 /PRNewswire/ –In a pioneering step towards elevating nursing education in Pakistan, has signed strategic Memorandum of Understanding (MoU) with the Institute of Contemporary Studies (ICS) and the National Excellence Institute (NEI). Pakistan faces a critical shortage of nursing professionals, with approximately 0.47 nurses and midwives per 1,000 people—significantly below the World Health Organization's recommended minimum of 2.5 per 1,000 (World Bank, 2019; International Labour Organization). In clinical settings, the ideal nurse-to-patient ratio is 3 nurses for every 10 patients, yet many facilities operate with fewer, affecting care quality and increasing workforce strain (Pakistan Nursing Council). ArthurAI™ licenses will initially target 2,000 nursing students within the first year, scaling to 10,000 nursing students within two years. Over the longer term, aims to empower 80,000 nurses nationwide with ArthurAI™, positioning this collaboration as a transformative force in Pakistan's nursing education and healthcare workforce development. Bill Faruki, CEO of stated 'Our partnerships with ICS and NEI reflect a shared commitment to harness AI's power in shaping the future of healthcare education in Pakistan. ArthurAI™ will empower both students and educators to achieve unprecedented levels of personalization, efficiency, and academic success.' Mohammad Aurangzeb Nadeem, Executive Director of ICS and NEI added 'We are excited to pioneer AI-driven transformation in nursing education. This unified effort will strengthen our academic programs, enhance student outcomes, and support Pakistan's healthcare sector with skilled nursing professionals ready for tomorrow's challenges.' About ICS & NEI Pakistan ICS, a leading private-sector institution, hosts and delivers the Post-RN BSN nursing program for Khyber Medical University, focusing on inclusive education and AI-enhanced curriculum development. NEI, a specialized healthcare education institute, advances nursing excellence and digital innovation by embedding ArthurAI™ as a virtual assistant within its Post-RN BSN program. About is redefining the boundaries of intelligence by engineering autonomous systems and deploying domain-specific AGI agents across real-world sectors. Powered by the Ava-Fusion™ large reasoning model and architected for agent coordination, swarm intelligence, and adaptive autonomy, MindHYVE's technology stack is revolutionizing law, medicine, finance, education, and governance. With operations in North America, Asia, and in Africa, is on a mission to democratize access to transformative intelligence and architect the infrastructure for post-scarcity economies. Backed by HYVE Labs, the company continues to shape the future of agentic systems on a global scale. Website: | Email: hello@ | Contact: +1 (949) 200-8668 Media ContactMarc OrtizEmail: Photo – – View original content:
Cision Canada
4 days ago
- Health
- Cision Canada
MindHYVE.ai Partners with ICS Pakistan and NEI Pakistan to Revolutionize Nursing Education with AI-Powered ArthurAI
ISLAMABAD, /CNW/ --In a pioneering step towards elevating nursing education in Pakistan, has signed strategic Memorandum of Understanding (MoU) with the Institute of Contemporary Studies (ICS) and the National Excellence Institute (NEI). Pakistan faces a critical shortage of nursing professionals, with approximately 0.47 nurses and midwives per 1,000 people—significantly below the World Health Organization's recommended minimum of 2.5 per 1,000 (World Bank, 2019; International Labour Organization). In clinical settings, the ideal nurse-to-patient ratio is 3 nurses for every 10 patients, yet many facilities operate with fewer, affecting care quality and increasing workforce strain (Pakistan Nursing Council). ArthurAI™ licenses will initially target 2,000 nursing students within the first year, scaling to 10,000 nursing students within two years. Over the longer term, aims to empower 80,000 nurses nationwide with ArthurAI™, positioning this collaboration as a transformative force in Pakistan's nursing education and healthcare workforce development. Bill Faruki, CEO of stated " Our partnerships with ICS and NEI reflect a shared commitment to harness AI's power in shaping the future of healthcare education in Pakistan. ArthurAI™ will empower both students and educators to achieve unprecedented levels of personalization, efficiency, and academic success." Mohammad Aurangzeb Nadeem, Executive Director of ICS and NEI added "We are excited to pioneer AI-driven transformation in nursing education. This unified effort will strengthen our academic programs, enhance student outcomes, and support Pakistan's healthcare sector with skilled nursing professionals ready for tomorrow's challenges." About ICS & NEI Pakistan ICS, a leading private-sector institution, hosts and delivers the Post-RN BSN nursing program for Khyber Medical University, focusing on inclusive education and AI-enhanced curriculum development. NEI, a specialized healthcare education institute, advances nursing excellence and digital innovation by embedding ArthurAI™ as a virtual assistant within its Post-RN BSN program. About is redefining the boundaries of intelligence by engineering autonomous systems and deploying domain-specific AGI agents across real-world sectors. Powered by the Ava-Fusion™ large reasoning model and architected for agent coordination, swarm intelligence, and adaptive autonomy, MindHYVE's technology stack is revolutionizing law, medicine, finance, education, and governance. With operations in North America, Asia, and in Africa, is on a mission to democratize access to transformative intelligence and architect the infrastructure for post-scarcity economies. Backed by HYVE Labs, the company continues to shape the future of agentic systems on a global scale. Media Contact Marc Ortiz Email: [email protected]
Cision Canada
23-07-2025
- Business
- Cision Canada
NEI announces change to its leadership team Français
TORONTO, July 23, 2025 /CNW/ - NEI Investments (NEI) today announced that Adelaide Chiu, VP, Head of Responsible Investing, departed the organization on July 14, 2025. Her responsibilities as portfolio manager of certain NEI funds have been assumed by John Bai, Chief Investment Officer, effective July 14, 2025. About NEI NEI Investments is part of the asset management arm of Aviso Wealth Inc. (Aviso), one of Canada's leading wealth services providers. NEI holds over $13 billion in assets under management as of June 30, 2025. NEI adopts a differentiated approach to achieving investment returns for Canadians, leveraging a unique structure that includes a global network of money managers, proprietary investment management and asset allocation and a dedicated responsible investing team. This structure is designed to optimally respond to the dynamics of a changing world, uncover unique investment opportunities, and deliver a broad array of investment outcomes with financial growth at the core. About Aviso Aviso is a leading wealth management services provider for the Canadian financial industry, with approximately $150 billion in total assets under administration and management as of June 30, 2025. We're building a technology-enabled, client-centric wealth management ecosystem. Our clients include our partners, advisors and investors. We're a trusted partner for nearly all credit unions across Canada, in addition to a wide range of portfolio managers, investment dealers, insurance and trust companies, and introducing brokers. Our partners depend on Aviso for specific solutions that give them a competitive edge in a rapidly evolving, highly competitive industry. Our dual-registered investment and mutual fund dealer and our insurance services support thousands of investment advisors. Our asset manager oversees a growing lineup of investment solutions, including NEI funds and portfolios. Our Managed Assets Program provides a comprehensive range of separately managed accounts. Our online brokerage, Qtrade Direct Investing®, empowers self-directed investors, and our fully automated investing service, Qtrade Guided Portfolios®, serves investors who prefer a hands-off approach. Aviso Correspondent Partners provides custodial and carrying broker services to a wide range of firms. Aviso is backed by the collective strength of our owners: the credit union Centrals, Desjardins, and Co-operators/CUMIS. We're proud to power businesses that empower investors. For more information visit Aviso is a wholly owned subsidiary of Aviso Wealth LP, which in turn is owned 50% by Desjardins Financial Holding Inc. and 50% by a limited partnership owned by the five provincial credit union Centrals and The CUMIS Group Limited. The following entities are subsidiaries of Aviso: Aviso Financial Inc. (including divisions Aviso Wealth, Qtrade Direct Investing, Qtrade Guided Portfolios, Aviso Correspondent Partners), Aviso Insurance Inc., Credential Insurance Services Inc. and Northwest & Ethical Investments L.P. NEI Investments is a registered trademark of Northwest & Ethical Investments L.P. (NEI LP). Northwest & Ethical Investments Inc. is the general partner of NEI LP and a wholly owned subsidiary of Aviso Wealth Inc. Online brokerage services are offered through Qtrade Direct Investing. Mutual funds and other securities are offered through Aviso Wealth. Qtrade Direct Investing, Qtrade Guided Portfolios, Aviso Correspondent Partners, and Aviso Wealth are divisions of Aviso Financial Inc. Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus and/or Fund Facts before investing. Mutual funds are not guaranteed, their values change frequently, and past performance may not be repeated.
Malaysian Reserve
13-06-2025
- Business
- Malaysian Reserve
Foundation CEO Provides Expert Testimony to U.S. Senate as Outside Witness on Vision Research Funding
Jason Menzo Urges Robust FY2026 Funding for National Eye Institute and Protection of Its Independent Status COLUMBIA, Md., June 13, 2025 /PRNewswire/ — The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, today submitted written testimony to the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies through its chief executive officer, Jason Menzo, who served as an expert outside witness. In the testimony, Menzo urged the Subcommittee to deliver robust and sustained funding for the National Eye Institute (NEI) in Fiscal Year 2026 and to preserve NEI's status as an independent institute within the National Institutes of Health (NIH). 'NEI is the only federal institute dedicated exclusively to vision research,' said Jason Menzo, CEO of the Foundation Fighting Blindness. 'Its work is restoring sight, advancing precision medicine, and delivering hope to millions of Americans living with retinal diseases. Continued investment is critical to maintaining momentum and achieving breakthroughs for conditions that currently have no cure.' The Foundation's testimony highlights how NEI-supported research has led to transformative discoveries, including the first FDA-approved gene therapy for an inherited disease, and emphasizes NEI's strategic role in public-private collaborations that accelerate treatment development. The Foundation Fighting Blindness and NEI have long shared a close, collaborative partnership to advance high-impact scientific discovery and bring new treatments to patients faster. Vision loss from diseases such as retinitis pigmentosa, macular degeneration, and Stargardt disease currently affects tens of millions and costs the U.S. economy an estimated $134.2 billion annually. The Foundation emphasized that inconsistent funding stalls clinical trials, closes labs, and risks losing top scientific talent—consequences that are difficult and costly to reverse. The testimony also noted that for every dollar invested in NIH-funded research, $2.56 in new economic activity is generated, making this one of the highest-return investments Congress can make. 'We're not just talking about restoring sight—we're talking about protecting America's leadership in biomedical innovation and supporting economic growth in communities nationwide,' added Menzo. The Foundation Fighting Blindness urges Congress to: Provide strong, sustained funding for NEI in the FY2026 Labor-HHS Appropriations bill; and Preserve NEI's status as an independent institute within NIH to ensure focused, strategic investment in vision science. The full testimony is available at About the Foundation Fighting BlindnessEstablished in 1971, the Foundation Fighting Blindness is the world's leading private source of funding for research on retinal degenerative diseases. The Foundation has raised over $954 million toward its mission to prevent, treat, and cure blinding diseases such as retinitis pigmentosa, age-related macular degeneration, Usher syndrome, and more. Visit for more information. Media Contacts:Chris AdamsVice President, Marketing & CommunicationsCAdams@ 423-0585
Yahoo
13-06-2025
- Business
- Yahoo
Foundation CEO Provides Expert Testimony to U.S. Senate as Outside Witness on Vision Research Funding
Jason Menzo Urges Robust FY2026 Funding for National Eye Institute and Protection of Its Independent Status COLUMBIA, Md., June 13, 2025 /PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, today submitted written testimony to the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies through its chief executive officer, Jason Menzo, who served as an expert outside witness. In the testimony, Menzo urged the Subcommittee to deliver robust and sustained funding for the National Eye Institute (NEI) in Fiscal Year 2026 and to preserve NEI's status as an independent institute within the National Institutes of Health (NIH). "NEI is the only federal institute dedicated exclusively to vision research," said Jason Menzo, CEO of the Foundation Fighting Blindness. "Its work is restoring sight, advancing precision medicine, and delivering hope to millions of Americans living with retinal diseases. Continued investment is critical to maintaining momentum and achieving breakthroughs for conditions that currently have no cure." The Foundation's testimony highlights how NEI-supported research has led to transformative discoveries, including the first FDA-approved gene therapy for an inherited disease, and emphasizes NEI's strategic role in public-private collaborations that accelerate treatment development. The Foundation Fighting Blindness and NEI have long shared a close, collaborative partnership to advance high-impact scientific discovery and bring new treatments to patients faster. Vision loss from diseases such as retinitis pigmentosa, macular degeneration, and Stargardt disease currently affects tens of millions and costs the U.S. economy an estimated $134.2 billion annually. The Foundation emphasized that inconsistent funding stalls clinical trials, closes labs, and risks losing top scientific talent—consequences that are difficult and costly to reverse. The testimony also noted that for every dollar invested in NIH-funded research, $2.56 in new economic activity is generated, making this one of the highest-return investments Congress can make. "We're not just talking about restoring sight—we're talking about protecting America's leadership in biomedical innovation and supporting economic growth in communities nationwide," added Menzo. The Foundation Fighting Blindness urges Congress to: Provide strong, sustained funding for NEI in the FY2026 Labor-HHS Appropriations bill; and Preserve NEI's status as an independent institute within NIH to ensure focused, strategic investment in vision science. The full testimony is available at About the Foundation Fighting BlindnessEstablished in 1971, the Foundation Fighting Blindness is the world's leading private source of funding for research on retinal degenerative diseases. The Foundation has raised over $954 million toward its mission to prevent, treat, and cure blinding diseases such as retinitis pigmentosa, age-related macular degeneration, Usher syndrome, and more. Visit for more information. Media Contacts:Chris AdamsVice President, Marketing & CommunicationsCAdams@ 423-0585 View original content to download multimedia: SOURCE Foundation Fighting Blindness
